How much is Palobiofarma worth in 2026?

Palobiofarma has a current valuation of $79.3M based on their Later Stage VC round and secondary market data.

How much funding has Palobiofarma raised?

Palobiofarma has raised $21.1M in total funding across 0 funding rounds.

Palobiofarma

Website

Palobiofarma valuation and funding history | Last updated: May 7, 2024

Current Valuation

$79.3M

As of May 7, 2024

Total Funding Raised

$21.1M

Last Round

Later Stage VC

$7.7M

Last Funding

May 2024

Funding date

Capital Efficiency

3.76x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Palobiofarma is currently valued at $79.3M as of May 7, 2024. The company has raised a total of $21.1M in funding.

Capital Efficiency

With a capital efficiency ratio of 3.76x, Palobiofarma has achieved a valuation that is 3.76 times the total capital raised.

Track Palobiofarma Valuation Updates

Get notified when Palobiofarma raises new funding or valuation changes

Explore More Data

Detailed analysis for Palobiofarma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Palobiofarma's valuation history, funding rounds, and growth metrics.

No credit card required

What is Palobiofarma Worth in 2026?

Palobiofarma is a leading private company in the technology sector. Track Palobiofarma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Palobiofarma Valuation is Determined

Private company valuations like Palobiofarma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.